The article frames all five as things to confirm before a first fill
Join us at Total Rejuvenation Medspa and make lasting wellness a reality
In January, Gov
For patients initiating tirzepatide, the following monitoring approach is recommended: Obtain baseline dilated eye examination before starting therapy, particularly in patients with known retinopathy Schedule follow-up ophthalmologic evaluation within 3 to 6 months of treatment initiation for patients with pre-existing retinopathy Maintain appropriate screening intervals (annual or every 1-2 years) for patients without baseline retinopathy based on glycemic control For pregnant women with preexisting diabetes, obtain an eye examination in the first trimester with close follow-up throughout pregnancy Coordinate care between primary care, endocrinology, and ophthalmology providers Patients should be instructed to seek immediate ophthalmologic evaluation (same-day or next-day) if they experience: Sudden vision loss or significant vision changes New floaters or flashing lights Curtain-like shadow across the visual field Persistent blurred vision not explained by refractive changes Healthcare providers should document baseline retinopathy status, communicate treatment plans with eye care specialists, and maintain awareness that optimal long-term glycemic controlachieved through medications like tirzepatideremains the most effective strategy for preventing vision-threatening diabetic eye disease
Hyperbaric oxygen therapy improves peripheral insulin sensitivity in humans
Research NAD+ Therapy Here BPC-157 + GLP-1 Weight Loss Therapy (Semaglutide or Tirzepatide) If you're on a medically supervised weight loss journey, BPC-157 can help protect your joints and tissues during the process, reduce inflammation, and support gut health, especially important as your body adapts to metabolic changes
